The dual role of PEDF in the pathogenesis of OHSS: Negating both angiogenic and inflammatory pathways

Irit Miller, Dana Chuderland, Hadas Grossman, Raphael Ron-El, Ido Ben-Ami, Ruth Shalgi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Context: Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of assisted reproductive technologies. This complex syndrome is known to involve massive angiogenesis and inflammation. We have previously established the anti-angiogenic involvement of pigment epithelium-derived factor (PEDF) in the pathophysiology and treatment of OHSS. Objective: Evaluate the anti-inflammatory role of PEDF in OHSS. Design: In vivo mouse OHSS model and in vitro cultures of granulosa cells. Main Outcome: Changes in the expression of PEDF, IL-6, IL-8, and vascular endothelial growth factor (VEGF) were measured by quantitative PCR and ELISA; OHSS symptoms were recorded (body and ovarian weight gain and peritoneal vascular leakage quantified by the modified Miles's assay). Results: Rat granulosa cell-line stimulated with lysophosphatidic acid (LPA), exhibited a significant increase in IL-6 expression, concomitantly with a decrease in PEDF level (P < .01). Co-stimulation with recombinant PEDF (rPEDF) decreased the expression of IL-6 significantly (P < .05). Furthermore, the expression of IL-6 and IL-8 increased in LPA-stimulated human primary granulosa cells (P < .01). Co-stimulation with rPEDF decreased the expression of LPA-induced IL-6 and IL-8 mRNA and protein by 4- and 2- to 5-fold, respectively. IL-8-stimulated human primary granulosa cells exhibited increased expression of VEGF mRNA; co-stimulation with hCG induced a significantly higher increase in the expression of VEGF mRNA (P < .001), which was counteracted by rPEDF. Subcutaneous injection of 0.5mg/kgrPEDF to OHSS-induced mice reduced the increased expression of IL-6 in the ovary (P < .01) and alleviated the severity of all OHSS parameters. Conclusions: Our findings provide a framework that correlates down-regulation of OHSS symptoms caused by PEDF with both angiogenic and inflammatory pathways.

Original languageEnglish
Pages (from-to)4699-4709
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Issue number12
StatePublished - Dec 2016


FundersFunder number
Israel Science Foundation1934/13


    Dive into the research topics of 'The dual role of PEDF in the pathogenesis of OHSS: Negating both angiogenic and inflammatory pathways'. Together they form a unique fingerprint.

    Cite this